Cover Image

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Arthritis & Rheumatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Images: Erosive tophaceous gout and uric acid nephrolithiasis: microscopic and three‐dimensional high‐resolution peripheral quantitative computed tomography findings
by: Giovanni Adami, et al.
Published: (2024)

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
by: Giovanni Adami, et al.
Published: (2025)

Temporal dissociation between clinical remission and microvascular improvement assessed by AI ‐assisted capillaroscopy in anti–Mi‐2 dermatomyositis: potential therapeutic implications
by: Angelo Nigro
Published: (2026)

Successful Spontaneous Pregnancies and Healthy Neonates After Dual‐Target CAR –T Cell Therapy in Systemic Lupus Erythematosus
by: Qinglian Jiang, et al.
Published: (2026)

Environment and Systemic Autoimmune Rheumatic Diseases: What Do We Know After More Than 15 Years of Research?
by: Jaime E. Hart, et al.
Published: (2025)

Weight Loss After Receiving Anti‐Obesity Medications and Gout Among Individuals With Overweight and Obese: A Population‐Based Cohort Study
by: Jie Wei, et al.
Published: (2024)

Dysregulated NUB1 and Neddylation Enhances Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Inflammatory Responses
by: Sho Sendo, et al.
Published: (2024)

Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double‐Blind, Placebo‐Controlled Trial
by: Karen H. Costenbader, et al.
Published: (2024)

The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
by: Piero Ruscitti, et al.
Published: (2024)

Implications of Inflammatory Processes on a Developing Central Nervous System in Childhood‐Onset Systemic Lupus Erythematosus
by: Hanne van der Heijden, et al.
Published: (2024)

Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross‐sectional Exploratory Study
by: Filippo Fagni, et al.
Published: (2024)

Single‐Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus
by: Haerin Jang, et al.
Published: (2026)

Toward a Treat‐to‐Target Strategy in Juvenile Dermatomyositis: What Are the Suitable Targets and Optimal Timing of Their Achievement?
by: Jayne M. MacMahon, et al.
Published: (2026)

Histone‐Specific CD4+ T Cell Plasticity in Active and Quiescent Systemic Lupus Erythematosus
by: Giuseppe A. Ramirez, et al.
Published: (2024)

Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha‐Amidating Monooxygenase Activity in Synovial Fibroblasts
by: Kevin J. Sheridan, et al.
Published: (2026)

Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
by: Elena Pontarini, et al.
Published: (2024)

Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis
by: Pamela F. Weiss, et al.
Published: (2024)

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel
by: Arsene Mekinian, et al.
Published: (2025)

Clinical Images: Local bone loss in a patient with acrodermatitis continua of Hallopeau
by: Francesco Bellinato, et al.
Published: (2026)

EULAR /American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis
by: Yongdong Zhao, et al.
Published: (2025)

In This Issue
Published: (2026)

Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders
by: Amber De Visscher, et al.
Published: (2026)

TWIST1 ‐Mediated Induction of AEBP1 in Fibroblast‐Like Synoviocytes Activates Transforming Growth Factor β Signaling to Drive Angiogenesis and Promote Rheumatoid Arthritis
by: Zhenyu Li, et al.
Published: (2026)

Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis
by: Tate M. Johnson, et al.
Published: (2026)

Multiparametric Profiling of Circulating Immune Cells Identifies an Expansion of CD25high Switched Memory B Cells in Osteoarthritis
by: Neety Sahu, et al.
Published: (2025)

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
by: Parameswaran K. Nair, et al.
Published: (2025)

Investigation of Lysosome‐Associated Membrane Protein 3 Highlighting the Role of Lysosome in Pathophysiology and Treatment of Sjögren Disease
by: Hiroyuki Nakamura, et al.
Published: (2025)

Loss of Tripartite Motif–Containing Protein 21 and UVB ‐Induced Systemic Inflammation by Regulating DNA ‐Sensing Pathways
by: Gantsetseg Tumurkhuu, et al.
Published: (2025)

Serum Proteomic Signatures of Rheumatoid Arthritis Risk and Response: Analysis of a Rheumatoid Arthritis Interception Trial
by: Marianna Jasenecova, et al.
Published: (2026)

Single‐Cell Transcriptomic Analysis on Multi‐Subtypes of Idiopathic Inflammatory Myopathy Reveals Pathologic Hallmarks Associated With Stromal Stem and Immune Cells in Damaged Skeletal Muscles
by: Zhiqin Wang, et al.
Published: (2026)

Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis
by: Yiming Luo, et al.
Published: (2025)

Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis
by: Andreas Kerschbaumer, et al.
Published: (2025)

Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases
by: Silje W. Syversen, et al.
Published: (2024)

Measuring the Impact: Magnetic Resonance Imaging Response of Sacroiliac Joints to Tumor Necrosis Factor Inhibitors in Youth With Axial Disease
by: Timothy G. Brandon, et al.
Published: (2026)

Integrated Clinical and Proteomic Profiling of CD19 CAR ‐T Cell Therapy in Progressive Systemic Sclerosis
by: Chenhan Jia, et al.
Published: (2026)

Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All
by: Stephen J. Balevic, et al.
Published: (2026)

Clinical Images: Bone Buds as Precursors to Ankylosis in Axial Spondyloarthritis
by: Lilach Shkolnik Arad, et al.
Published: (2026)

“Negative” finding supports two‐hit model: comment on the article by Kroese et al
by: Ronald van Vollenhoven
Published: (2025)

Reply
by: Yun Kyu Kim, et al.
Published: (2025)

The Emerging Spectrum of Somatic Mutation in Rheumatic Disease: Clonal Hematopoiesis Connects Aging With Giant Cell Arteritis
by: Richard Bucala, et al.
Published: (2024)